Blackrock Inc vs DexCom, Inc. — how do they compare? Blackrock Inc trades at $1,144.15 (market cap $177.92B), while DexCom, Inc. trades at $89.2 (market cap $33.79B). The key difference: Blackrock Inc is far larger — about 5.3× DexCom, Inc.'s market cap, and Blackrock Inc pays a 2% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| BLK | DXCM | |
|---|---|---|
Market Cap | $177.92B | $33.79B |
Volume | 641,547 | — |
Sector | Financials | Health |
52-Week High | $1.20K | $89.53 |
52-Week Low | $922.90 | $54.84 |
Enterprise Value | $179.02B | $33.24B |
Dividend Yield | 2% | — |
Trailing returns across standard periods
Latest headlines on both assets
BlackRock, Inc. provides investment management services to institutional clients and to retail investors through various investment vehicles. The Company manages funds, as well as offers risk management services. BlackRock serves governments, companies, and foundations worldwide.
Read more on BLK →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →